EGF Theramed Health Corp.
EVAHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $0 | $0 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $1 |
| Operating Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | $0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$0 | -$1 | -$1 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | -$2 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.024 | -0.062 | -0.63 |
| % Growth | -733.3% | 61.5% | 90.1% | – |
| EPS Diluted | -0.2 | -0.024 | -0.062 | -0.63 |
| Weighted Avg Shares Out | 12 | 11 | 10 | 2 |
| Weighted Avg Shares Out Dil | 12 | 11 | 10 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |